FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the use of carnosol and/or rosmanol for preventing and treating the conditions associated with decreased transmitter/mediator activity of serotonine, dopamine and noradrenaline. Carnosol and/or rosmanol are used as ingredients of food and pharmaceutical compositions.
EFFECT: invention provides preventing the disorders associated with weak nerve signal transfer.
5 cl, 5 dwg, 9 tbl, 16 ex
Authors
Dates
2012-01-20—Published
2007-11-22—Filed